LPL Financial’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-38,780
| Closed | -$798K | – | 4745 |
|
|
2023
Q2 | $798K | Sell |
38,780
-16,472
| -30% | -$339K | ﹤0.01% | 3014 |
|
|
2023
Q1 | $1.13M | Buy |
55,252
+1,661
| +3% | +$34K | ﹤0.01% | 2654 |
|
|
2022
Q4 | $1.2M | Sell |
53,591
-7,685
| -13% | -$172K | ﹤0.01% | 2498 |
|
|
2022
Q3 | $1.27M | Buy |
61,276
+2,149
| +4% | +$44.5K | ﹤0.01% | 2343 |
|
|
2022
Q2 | $1.38M | Buy |
59,127
+1,642
| +3% | +$38.2K | ﹤0.01% | 2312 |
|
|
2022
Q1 | $1.57M | Sell |
57,485
-2,158
| -4% | -$59.1K | ﹤0.01% | 2231 |
|
|
2021
Q4 | $2.13M | Sell |
59,643
-2
| -0% | -$71 | ﹤0.01% | 2038 |
|
|
2021
Q3 | $2.45M | Buy |
59,645
+520
| +0.9% | +$21.3K | ﹤0.01% | 1891 |
|
|
2021
Q2 | $2.37M | Buy |
59,125
+20,263
| +52% | +$811K | ﹤0.01% | 1832 |
|
|
2021
Q1 | $1.38M | Buy |
38,862
+11,916
| +44% | +$423K | ﹤0.01% | 2122 |
|
|
2020
Q4 | $838K | Buy |
+26,946
| New | +$838K | ﹤0.01% | 2323 |
|